Opiant Pharmaceuticals Inc (NASDAQ:OPNT)

14.86
Delayed Data
As of Jun 22
 +0.2231 / +1.52%
Today’s Change
5.06
Today|||52-Week Range
51.90
-35.31%
Year-to-Date
No recent news for Opiant Pharmaceuticals Inc.

Today’s Trading

Previous close14.64
Today’s open14.57
Day’s range13.98 - 14.86
Volume23,332
Average volume (3 months)33,739
Market cap$48.8M
Data as of 4:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+86.37%
P/E ratio31.6
Price/Sales1.58
Price/Book8.45

Competitors

 Today’s
change
Today’s
% change
APDNApplied DNA Sciences...+0.09+7.28%
XENEXenon Pharmaceutical...-0.15-1.91%
PLXPPLX Pharma Inc+0.08+1.96%
CASICASI Pharmaceuticals...+0.57+9.98%
Data as of 4:00pm ET, 06/22/2018

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$18.4M
Annual profit (last year)$6.6M
Net profit margin35.68%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Head-Media Relations
Roger Crystal
Chief Financial Officer
David D. O'Toole
Corporate headquarters
Santa Monica, California

Forecasts